Diagnostic performance and reference values of novel biomarkers of paediatric heart failure

Heart

Volumn 102, Issue 20, 2016, Pages 1633-1639

  Hauser, Jakob A ^a,b,c   Demyanets, Svitlana ^d   Rusai, Krisztina ^a   Goritschan, Clara ^a   Weber, Michael ^d   Panesar, Dilveer ^b,c   Rindler, Lisa ^a   Taylor, Andrew M ^b,c   Marculescu, Rodrig ^d   Burch, Michael ^c   Wojta, Johann ^d   Michel Behnke, Ina ^a  

^a UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; GROWTH DIFFERENTIATION FACTOR 15; PROADRENOMEDULLIN; SOMATOSTATIN RECEPTOR 2; ADM PROTEIN, HUMAN; ADRENOMEDULLIN; ATRIAL NATRIURETIC FACTOR; GDF15 PROTEIN, HUMAN; IL1RL1 PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROTEIN PRECURSOR;

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SEX DIFFERENCE; ADOLESCENT; AGE; AREA UNDER THE CURVE; AUSTRIA; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; INFANT; MULTICENTER STUDY; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRESCHOOL CHILD; REPRODUCIBILITY; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADRENOMEDULLIN; AGE FACTORS; AREA UNDER CURVE; ATRIAL NATRIURETIC FACTOR; AUSTRIA; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GROWTH DIFFERENTIATION FACTOR 15; HEART FAILURE; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; MAGNETIC RESONANCE IMAGING; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; ROC CURVE; UNITED KINGDOM; YOUNG ADULT;

EID: 84973320436     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-309460     Document Type: Article

References (30)

1. Hsu DT, Pearson GD. Heart failure in children: part I: history, etiology, pathophysiology. Circ Heart Fail 2009;2:63-70.
2. Mangat J, Carter C, Riley G, et al. The clinical utility of brain natriuretic peptide in paediatric left ventricular failure. Eur J Heart Fail 2009;11:48-52.
3. Heise G, Lemmer J, Weng Y, et al. Biomarker responses during mid-term mechanical cardiac support in children. J Heart Lung Transplant 2008;27:150-7.
4. von Haehling S, Jankowska EA, Morgenthaler NG, et al. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol 2007;50:1973-80.
5. Gaggin HK, Januzzi JL Jr. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 2013;1832:2442-50.
6. Cantinotti M, Law Y, Vittorini S, et al. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, management of children with heart failure due to congenital cardiac disease: an update. Heart Fail Rev 2014;19:727-42.
7. Lassus J, Gayat E, Mueller C, et al. Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol 2013;168:2186-94.
8. Bayes-Genis A, de Antonio M, Galán A, et al. Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure. Eur J Heart Fail 2012;14:32-8.
9. Santhanakrishnan R, Chong JP, Ng TP, et al. Growth differentiation factor 15, ST2, high-sensitivity troponin T, N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction. Eur J Heart Fail 2012;14:1338-47.
10. Sabatine MS, Morrow DA, Higgins LJ, et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 2008;117:1936-44.
11. Koestenberger M, Ravekes W, Everett AD, et al. Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values. J Am Soc Echocardiogr 2009;22:715-19.
12. Ross RD. The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol 2012;33:1295-300.
13. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63.
14. Robbers-Visser D, Boersma E, Helbing WA. Normal biventricular function, volumes, mass in children aged 8 to 17 years. J Magn Reson Imaging 2009;29:552-9.
15. Kampmann C, Wiethoff CM, Wenzel A, et al. Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000;83:667-72.
16. Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77.
17. Clinical and Laboratory Standards Institute. CLSI. Defining, establishing, verifying reference intervals in the clinical laboratory. 3rd edn. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
19. Grass B, Baumann P, Arlettaz R, et al. Cardiovascular biomarkers pro-atrial natriuretic peptide and pro-endothelin-1 to monitor ductus arteriosus evolution in very preterm infants. Early Hum Dev 2014;90:293-8.
20. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
21. McGrath MF, de Bold ML, de Bold AJ. The endocrine function of the heart. Trends Endocrinol Metab 2005;16:469-77.
22. Weinberg EO, Shimpo M, Hurwitz S, et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 2003;107:721-6.
23. Dieplinger B, Januzzi JL Jr, Steinmair M, et al. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma-the Presage ST2 assay. Clin Chim Acta 2009;409:33-40.
24. Sato YZ, Molkara DP, Daniels LB, et al. Cardiovascular biomarkers in acute Kawasaki disease. Int J Cardiol 2013;164:58-63.
25. Norozi K, Buchhorn R, Yasin A, et al. Growth differentiation factor 15: an additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects? Am Heart J 2011;162:131-5.
26. Eindhoven JA, van den Bosch AE, Oemrawsingh RM, et al. Release of growth-differentiation factor 15 and associations with cardiac function in adult patients with congenital heart disease. Int J Cardiol 2016;202:246-51.
27. Raedle-Hurst TM, Koenigstein K, Gruenhage F, et al. Growth differentiation factor 15-an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts. Am Heart J 2010;160:1105-12.
28. Kaiser R, Abdul-Khaliq H, Wilkens H, et al. Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts? Eur J Heart Fail 2014;16:1082-8.
29. Koch L, Dabek MT, Frommhold D, et al. Stable precursor fragments of vasoactive peptides in umbilical cord blood of term and preterm infants. Horm Res Paediatr 2011;76:234-9.
30. Meeusen JW, Johnson JN, Gray A, et al. Soluble ST2 and galectin-3 in pediatric patients without heart failure. Clin Biochem 2015;48:1337-40.